The effects of verapamil on the electrophysiology of the intact immature mammalian heart

A. S. Pickoff, C. J. Flinn, S. Singh, H. Gelband

Research output: Contribution to journalArticle

Abstract

The electrophysiological effects of intravenous verapamil were compared in six intact neonatal puppies ages 3-15 days and in adult dogs. Utilizing standard intracardiac recording and programmed stimulation techniques, sinus and AV nodal function and atrial and ventricular refractory periods were determined following incremental intravenous doses of 0.075 mg/kg, 0.15 mg/kg, and 0.30 mg/kg of verapamil. In the neonate, intravenous verapamil resulted in a significant increase of the sinus cycle length (37 ± 6%) but no changes occurred in either the percent sinus node recovery time or the corrected sinus node recovery time. The atrial effective refractory period was prolonged by verapamil (32 ± 12%). Concerning atrioventricular (AV) nodal function, verapamil produced a small but significant prolongation of resting AH interval (50.5 ± 2.4 ms (control) versus 57.3 ± 4.7 ms post 0.30 mg/kg) and a dose-related prolongation of the paced cycle length resulting in AV nodal Wenckebach (170 ± 12.8 ms control, 190 ± 10.3 ms post 0.075 mg/kg, 215.8 ± 13.0 ms post 0.15 mg/kg and 246.7 ± 22.8 ms post 0.30 mg/kg). The effective refractory period (ERP) and functional refractory period (FRP) of the atrioventricular node (AVN) were prolonged in a dose-dependent fashion (ERP-AVN; 75 ± 19% increase, FRP-AVN: 42 ± 14% increase). Retrograde conduction, present in all six neonates, was completely abolished in four of six subjects and significantly prolonged in one other puppy by verapamil. No changes in ventricular refractory periods were observed. Comparison of the neonatal data with data obtained in adult dogs studied by identical protocol, suggested that in the neonate verapamil tends to have more of an effect on sinus cycle and atrial ERP. The suppression of AVN conduction by verapamil appeared comparable in both the neonatal and adult subjects.

Original languageEnglish
Pages (from-to)125-130
Number of pages6
JournalJournal of Cardiovascular Pharmacology
Volume7
Issue number1
StatePublished - Jan 1 1985
Externally publishedYes

Fingerprint

Electrophysiology
Verapamil
Atrioventricular Node
Sinoatrial Node
Newborn Infant
Atrial Function
Dogs
Ventricular Function

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

The effects of verapamil on the electrophysiology of the intact immature mammalian heart. / Pickoff, A. S.; Flinn, C. J.; Singh, S.; Gelband, H.

In: Journal of Cardiovascular Pharmacology, Vol. 7, No. 1, 01.01.1985, p. 125-130.

Research output: Contribution to journalArticle

Pickoff, AS, Flinn, CJ, Singh, S & Gelband, H 1985, 'The effects of verapamil on the electrophysiology of the intact immature mammalian heart', Journal of Cardiovascular Pharmacology, vol. 7, no. 1, pp. 125-130.
Pickoff, A. S. ; Flinn, C. J. ; Singh, S. ; Gelband, H. / The effects of verapamil on the electrophysiology of the intact immature mammalian heart. In: Journal of Cardiovascular Pharmacology. 1985 ; Vol. 7, No. 1. pp. 125-130.
@article{0ad00dd235f84129951b411e6e638e0b,
title = "The effects of verapamil on the electrophysiology of the intact immature mammalian heart",
abstract = "The electrophysiological effects of intravenous verapamil were compared in six intact neonatal puppies ages 3-15 days and in adult dogs. Utilizing standard intracardiac recording and programmed stimulation techniques, sinus and AV nodal function and atrial and ventricular refractory periods were determined following incremental intravenous doses of 0.075 mg/kg, 0.15 mg/kg, and 0.30 mg/kg of verapamil. In the neonate, intravenous verapamil resulted in a significant increase of the sinus cycle length (37 ± 6{\%}) but no changes occurred in either the percent sinus node recovery time or the corrected sinus node recovery time. The atrial effective refractory period was prolonged by verapamil (32 ± 12{\%}). Concerning atrioventricular (AV) nodal function, verapamil produced a small but significant prolongation of resting AH interval (50.5 ± 2.4 ms (control) versus 57.3 ± 4.7 ms post 0.30 mg/kg) and a dose-related prolongation of the paced cycle length resulting in AV nodal Wenckebach (170 ± 12.8 ms control, 190 ± 10.3 ms post 0.075 mg/kg, 215.8 ± 13.0 ms post 0.15 mg/kg and 246.7 ± 22.8 ms post 0.30 mg/kg). The effective refractory period (ERP) and functional refractory period (FRP) of the atrioventricular node (AVN) were prolonged in a dose-dependent fashion (ERP-AVN; 75 ± 19{\%} increase, FRP-AVN: 42 ± 14{\%} increase). Retrograde conduction, present in all six neonates, was completely abolished in four of six subjects and significantly prolonged in one other puppy by verapamil. No changes in ventricular refractory periods were observed. Comparison of the neonatal data with data obtained in adult dogs studied by identical protocol, suggested that in the neonate verapamil tends to have more of an effect on sinus cycle and atrial ERP. The suppression of AVN conduction by verapamil appeared comparable in both the neonatal and adult subjects.",
author = "Pickoff, {A. S.} and Flinn, {C. J.} and S. Singh and H. Gelband",
year = "1985",
month = "1",
day = "1",
language = "English",
volume = "7",
pages = "125--130",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The effects of verapamil on the electrophysiology of the intact immature mammalian heart

AU - Pickoff, A. S.

AU - Flinn, C. J.

AU - Singh, S.

AU - Gelband, H.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - The electrophysiological effects of intravenous verapamil were compared in six intact neonatal puppies ages 3-15 days and in adult dogs. Utilizing standard intracardiac recording and programmed stimulation techniques, sinus and AV nodal function and atrial and ventricular refractory periods were determined following incremental intravenous doses of 0.075 mg/kg, 0.15 mg/kg, and 0.30 mg/kg of verapamil. In the neonate, intravenous verapamil resulted in a significant increase of the sinus cycle length (37 ± 6%) but no changes occurred in either the percent sinus node recovery time or the corrected sinus node recovery time. The atrial effective refractory period was prolonged by verapamil (32 ± 12%). Concerning atrioventricular (AV) nodal function, verapamil produced a small but significant prolongation of resting AH interval (50.5 ± 2.4 ms (control) versus 57.3 ± 4.7 ms post 0.30 mg/kg) and a dose-related prolongation of the paced cycle length resulting in AV nodal Wenckebach (170 ± 12.8 ms control, 190 ± 10.3 ms post 0.075 mg/kg, 215.8 ± 13.0 ms post 0.15 mg/kg and 246.7 ± 22.8 ms post 0.30 mg/kg). The effective refractory period (ERP) and functional refractory period (FRP) of the atrioventricular node (AVN) were prolonged in a dose-dependent fashion (ERP-AVN; 75 ± 19% increase, FRP-AVN: 42 ± 14% increase). Retrograde conduction, present in all six neonates, was completely abolished in four of six subjects and significantly prolonged in one other puppy by verapamil. No changes in ventricular refractory periods were observed. Comparison of the neonatal data with data obtained in adult dogs studied by identical protocol, suggested that in the neonate verapamil tends to have more of an effect on sinus cycle and atrial ERP. The suppression of AVN conduction by verapamil appeared comparable in both the neonatal and adult subjects.

AB - The electrophysiological effects of intravenous verapamil were compared in six intact neonatal puppies ages 3-15 days and in adult dogs. Utilizing standard intracardiac recording and programmed stimulation techniques, sinus and AV nodal function and atrial and ventricular refractory periods were determined following incremental intravenous doses of 0.075 mg/kg, 0.15 mg/kg, and 0.30 mg/kg of verapamil. In the neonate, intravenous verapamil resulted in a significant increase of the sinus cycle length (37 ± 6%) but no changes occurred in either the percent sinus node recovery time or the corrected sinus node recovery time. The atrial effective refractory period was prolonged by verapamil (32 ± 12%). Concerning atrioventricular (AV) nodal function, verapamil produced a small but significant prolongation of resting AH interval (50.5 ± 2.4 ms (control) versus 57.3 ± 4.7 ms post 0.30 mg/kg) and a dose-related prolongation of the paced cycle length resulting in AV nodal Wenckebach (170 ± 12.8 ms control, 190 ± 10.3 ms post 0.075 mg/kg, 215.8 ± 13.0 ms post 0.15 mg/kg and 246.7 ± 22.8 ms post 0.30 mg/kg). The effective refractory period (ERP) and functional refractory period (FRP) of the atrioventricular node (AVN) were prolonged in a dose-dependent fashion (ERP-AVN; 75 ± 19% increase, FRP-AVN: 42 ± 14% increase). Retrograde conduction, present in all six neonates, was completely abolished in four of six subjects and significantly prolonged in one other puppy by verapamil. No changes in ventricular refractory periods were observed. Comparison of the neonatal data with data obtained in adult dogs studied by identical protocol, suggested that in the neonate verapamil tends to have more of an effect on sinus cycle and atrial ERP. The suppression of AVN conduction by verapamil appeared comparable in both the neonatal and adult subjects.

UR - http://www.scopus.com/inward/record.url?scp=0021987789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021987789&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 125

EP - 130

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 1

ER -